Log in | Register

Diuretics in cardiorenal syndrome: what’s new?

Frederik H. Verbrugge| Kevin Damman| W. H. Wilson Tang
What's New in Intensive Care
Volume 44, Issue 3 / March , 2018

Pages 359 - 362

No abstract available.

References

  1. Metra M, Davison B, Bettari L, Sun H, Edwards C, Lazzarini V et al (2012) Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ Heart Fail 5(1):54–62
    • View reference on publisher's website
    • View reference on PubMed
  2. Coca SG, Zabetian A, Ferket BS, Zhou J, Testani JM, Garg AX et al (2016) Evaluation of short-term changes in serum creatinine level as a meaningful end point in randomized clinical trials. J Am Soc Nephrol 27(8):2529–2542
    • View reference on publisher's website
    • View reference on PubMed
  3. van Veldhuisen DJ, Ruilope LM, Maisel AS, Damman K (2016) Biomarkers of renal injury and function: diagnostic, prognostic and therapeutic implications in heart failure. Eur Heart J 37(33):2577–2585
    • View reference on publisher's website
    • View reference on PubMed
  4. Verbrugge FH, Dupont M, Steels P, Grieten L, Swennen Q, Tang WH et al (2014) The kidney in congestive heart failure: ‘are natriuresis, sodium, and diuretics really the good, the bad and the ugly?’. Eur J Heart Fail 16(2):133–142
    • View reference on publisher's website
    • View reference on PubMed
  5. Testani JM, Brisco MA, Turner JM, Spatz ES, Bellumkonda L, Parikh CR et al (2014) Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure. Circ Heart Fail 7(2):261–270
    • View reference on publisher's website
    • View reference on PubMed
  6. Verbrugge FH, Mullens W, Tang WH (2016) Management of cardio-renal syndrome and diuretic resistance. Curr Treat Options Cardiovasc Med 18(2):11
    • View reference on publisher's website
    • View reference on PubMed
  7. Kula AJ, Hanberg JS, Wilson FP, Brisco MA, Bellumkonda L, Jacoby D et al (2016) Influence of titration of neurohormonal antagonists and blood pressure reduction on renal function and decongestion in decompensated heart failure. Circ Heart Fail 9(1):e002333
    • View reference on publisher's website
    • View reference on PubMed
  8. Testani JM, Hanberg JS, Cheng S, Rao V, Onyebeke C, Laur O et al (2016) Rapid and highly accurate prediction of poor loop diuretic natriuretic response in patients with heart failure. Circ Heart Fail 9(1):e002370
    • View reference on publisher's website
    • View reference on PubMed
  9. Grodin JL, Verbrugge FH, Ellis SG, Mullens W, Testani JM, Tang WH (2016) Importance of abnormal chloride homeostasis in stable chronic heart failure. Circ Heart Fail. 9(1):e002453
    • View reference on publisher's website
    • View reference on PubMed
  10. Ter Maaten JM, Damman K, Hanberg JS, Givertz MM, Metra M, O’Connor CM, et al. (2016) Hypochloremia, diuretic resistance, and outcome in patients with acute heart failure. Circ Heart Fail 9(8): e003109. doi:10.1161/CIRCHEARTFAILURE.116.003109
    • View reference on publisher's website
    • View reference on PubMed
  11. Grodin JL, Sun JL, Anstrom KJ, Chen HH, Starling RC, Testani JM et al (2017) Implications of serum chloride homeostasis in acute heart failure (from ROSE-AHF). Am J Cardiol 119(1):78–83
    • View reference on publisher's website
    • View reference on PubMed
  12. Verbrugge FH, Dupont M, Bertrand PB, Nijst P, Penders J, Dens J et al (2015) Determinants and impact of the natriuretic response to diuretic therapy in heart failure with reduced ejection fraction and volume overload. Acta Cardiol 70(3):265–273
    • View reference on publisher's website
    • View reference on PubMed
  13. Tietjens J, Teerlink JR (2016) Serelaxin and acute heart failure. Heart 102(2):95–99
    • View reference on publisher's website
    • View reference on PubMed
  14. Jhund PS, McMurray JJ (2016) The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan. Heart 102(17):1342–1347
    • View reference on publisher's website
    • View reference on PubMed
  15. Wanner C, Inzucchi SE, Lachin JM, Fitchett D, von Eynatten M, Mattheus M et al (2016) Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl J Med 375(4):323–334
    • View reference on publisher's website
    • View reference on PubMed
  16. Valente MA, Voors AA, Damman K et al (2014) Diuretic response in acute heart failure: clinical characteristics and prognostic significance. Eur Heart J 35:1284–1293
    • View reference on publisher's website
    • View reference on PubMed
  17. Voors AA, Davison BA, Teerlink JR et al (2014) Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome–an analysis from RELAX-AHF. Eur J Heart Fail 16:1230–1240
    • View reference on publisher's website
    • View reference on PubMed
  18. Singh D, Shrestha K, Testani JM et al (2014) Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure. J Card Fail 20:392–399
    • View reference on publisher's website
    • View reference on PubMed
  19. Ter Maaten JM, Dunning AM, Valente MA et al (2015) Diuretic response in acute heart failure—an analysis from ASCEND-HF. Am Heart J 170(313–21):e4
  20. Kumar D, Bagarhatta R (2015) Fractional excretion of sodium and its association with prognosis of decompensated heart failure patients. J Clin Diagn Res 9:OC01-3
    • View reference on PubMed
  21. Aronson D, Burger AJ (2016) Diuretic response: clinical and hemodynamic predictors and relation to clinical outcome. J Card Fail 22:193–200
    • View reference on publisher's website
    • View reference on PubMed

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement